‘No’ urged for OTC sale of drug
From Times Wire Services
The government should reject Merck & Co. Inc.’s third bid to sell a cholesterol-lowering pill without a doctor’s prescription, an advisory panel ruled.
Advisors to the Food and Drug Administration voted 10 to 2 with one abstention against Merck’s proposal for a low-dose, over-the-counter version of its cholesterol fighter Mevacor.
FDA officials usually follow the panel’s recommendations.
